4front Ventures Corp Stock Number Of Shares Shorted

If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Based on the recorded statements, 4Front Ventures Corp has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze 4Front Ventures Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Front Ventures using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Front Ventures Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

4Front Ventures financial ratios help investors to determine whether 4Front OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 4Front with respect to the benefits of owning 4Front Ventures security.